1. Home
  2. SNWV vs NNNN Comparison

SNWV vs NNNN Comparison

Compare SNWV & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNWV
  • NNNN
  • Stock Information
  • Founded
  • SNWV 2004
  • NNNN 2021
  • Country
  • SNWV United States
  • NNNN Germany
  • Employees
  • SNWV N/A
  • NNNN N/A
  • Industry
  • SNWV
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SNWV
  • NNNN Health Care
  • Exchange
  • SNWV NYSE
  • NNNN Nasdaq
  • Market Cap
  • SNWV 234.2M
  • NNNN 267.7M
  • IPO Year
  • SNWV N/A
  • NNNN 2025
  • Fundamental
  • Price
  • SNWV $26.20
  • NNNN $7.87
  • Analyst Decision
  • SNWV
  • NNNN
  • Analyst Count
  • SNWV 0
  • NNNN 0
  • Target Price
  • SNWV N/A
  • NNNN N/A
  • AVG Volume (30 Days)
  • SNWV 46.1K
  • NNNN 44.5K
  • Earning Date
  • SNWV 05-08-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • SNWV N/A
  • NNNN N/A
  • EPS Growth
  • SNWV N/A
  • NNNN N/A
  • EPS
  • SNWV N/A
  • NNNN 0.06
  • Revenue
  • SNWV $36,190,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • SNWV N/A
  • NNNN N/A
  • Revenue Next Year
  • SNWV N/A
  • NNNN N/A
  • P/E Ratio
  • SNWV N/A
  • NNNN $140.27
  • Revenue Growth
  • SNWV 61.50
  • NNNN 21.95
  • 52 Week Low
  • SNWV $5.18
  • NNNN $5.18
  • 52 Week High
  • SNWV $39.50
  • NNNN $8.22
  • Technical
  • Relative Strength Index (RSI)
  • SNWV N/A
  • NNNN N/A
  • Support Level
  • SNWV N/A
  • NNNN N/A
  • Resistance Level
  • SNWV N/A
  • NNNN N/A
  • Average True Range (ATR)
  • SNWV 0.00
  • NNNN 0.00
  • MACD
  • SNWV 0.00
  • NNNN 0.00
  • Stochastic Oscillator
  • SNWV 0.00
  • NNNN 0.00

About SNWV SANUWAVE HEALTH INC

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: